Choosing InnoCARE means training across all dimensions of integrated physiology and pathophysiology, from disease characterization to disease modelling, with the goal of identifying new therapeutic strategies.
Students are trained in innovative approaches to the study of pathophysiology and the treatment of diseases, including:
- Genomics, genetics, and transcriptomics
- Disease modelling using stem cells, organoids, or animal models
- Integrative phenotyping (multimodal imaging, electrophysiology)
- Bioanalysis and bioinformatics
- Biomarker identification and development of innovative therapies
- Cardiovascular, metabolic, and respiratory diseases remain major causes of mortality worldwide. This master's program provides strong career prospects in academic, industrial, and clinical research, as well as opportunities to pursue a PhD.
Over the two-year program, students can tailor their training by selecting among three possible tracks: clinical research, experimental research, research and analysis of omics data.
Experimental Research track : Designed for students wishing to pursue careers in academic research or biomedical research in industry.
- It develops key skills in scientific reasoning, experimental methodologies, and critical analysis of data in life and health sciences
- It emphasizes experimental design, mastery laboratory techniques, and rigorous interpretation of scientific results
Clinical Research track : Designed for students wishing to translate today’s knowledge into tomorrow’s therapies.
- It develops skills required to understand pathophysiological mechanisms, design and conduct clinical studies, and evaluate new treatments or medical devices
- It focuses on clinical trial methodology, clinical data analysis, and regulatory aspects of health.
Research and analysis of omics data : Designed for students wishing to specialise in bioinformatics and omics data analysis.
- It develops expertise in exploring complex relationships between genes, proteins, metabolites, and other biomolecules
- It focuses on multidimensional approaches, cutting-edge computational tools, and integrative interpretation of omics datasets
Why choose this Master’s programme?
- Translational approach to diseases: arrhythmias, valvular diseases, diabetes, obesity, asthma, hypertension, aneurysms, etc.
- Innovative methods and technologies: genomics, stem cells, organoids, genome editing (CRISPR/Cas9), cell biology, animal models, imaging, electrophysiology, biomarkers, molecular medicine, biotherapies
- Laboratory immersion
- Career opportunities at Master’s (Bac+5) and PhD level (Bac+8) in academic, private, and clinical sectors
- Personalized student support
- International mobility opportunities
Our International Partnerships
What mobility support is available?
The InnoCARE Master’s programme contributes to the funding of incoming and outgoing international mobility. For more information, please contact the programme coordinators.
Our class patrons
2025–2026: Marianne Abi Fadel – Sorbonne University & Saint Joseph University of Beirut (Lebanon)
2024–2025: Connie Bezzina – UMC Amsterdam (Netherlands)
2023–2024: Jean-Claude Tardif – Montreal Heart Institute (Canada)
2026–2027: Holger Gerhardt, Max Delbrück Centre (Berlin, Germany)
Master 1
